BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17970662)

  • 1. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharmaceutical Ingredients (APIs).
    Souto EB; Macedo AS; Dias-Ferreira J; Cano A; Zielińska A; Matos CM
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and opportunities in dermal/transdermal delivery.
    Paudel KS; Milewski M; Swadley CL; Brogden NK; Ghosh P; Stinchcomb AL
    Ther Deliv; 2010 Jul; 1(1):109-31. PubMed ID: 21132122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Navigating Skin Delivery Horizon: An Innovative Approach in Pioneering Surface Modification of Ultradeformable Vesicles.
    Nayak D; Rathnanand M; Tippavajhala VK
    AAPS PharmSciTech; 2024 Jun; 25(5):126. PubMed ID: 38834910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanovesicular ultraflexible invasomes and invasomal gel for transdermal delivery of phytopharmaceuticals.
    Sahu AN; Mohapatra D; Acharya PC
    Nanomedicine (Lond); 2024 Apr; 19(9):737-740. PubMed ID: 38420893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to and through the skin.
    Guy RH
    Drug Deliv Transl Res; 2024 Aug; 14(8):2032-2040. PubMed ID: 38837116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic and cosmeceutical potential of ethosomes: An overview.
    Verma P; Pathak K
    J Adv Pharm Technol Res; 2010 Jul; 1(3):274-82. PubMed ID: 22247858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancements in Skin-Mediated Drug Delivery: Mechanisms, Techniques, and Applications.
    Lee DH; Lim S; Kwak SS; Kim J
    Adv Healthc Mater; 2024 Mar; 13(7):e2302375. PubMed ID: 38009520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical Considerations, Applications, and Benefits of Organogels in Topical Drug Delivery Systems.
    Yadav A; Jhawat V; Singh RP; Chauhan S; Dutt R; Goyal R; Singh D
    Recent Adv Drug Deliv Formul; 2024; 18(1):12-20. PubMed ID: 38385494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the Effect of Aging on the Transport of Molecules through the Skin.
    de Mello T; Argenta DF; Caon T
    Pharm Res; 2024 Jun; 41(6):1031-1044. PubMed ID: 38740664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of transdermal absorption rate by nonthermal biocompatible atmospheric pressure plasma.
    Kim BC; Rana JN; Choi EH; Han I
    Drug Metab Pharmacokinet; 2024 Feb; 54():100536. PubMed ID: 38081105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycerosomes: Novel Nano-Vesicles for Efficient Delivery of Therapeutics.
    Sharma D; Rani A; Singh VD; Shah P; Sharma S; Kumar S
    Recent Adv Drug Deliv Formul; 2023; 17(3):173-182. PubMed ID: 37921130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Pharmacokinetics of Topically Applied Novel Dermatological Formulations.
    Patel M; Patel A; Desai J; Patel S
    AAPS PharmSciTech; 2024 Feb; 25(3):46. PubMed ID: 38413430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo methods for the assessment of topical drug bioavailability.
    Herkenne C; Alberti I; Naik A; Kalia YN; Mathy FX; Préat V; Guy RH
    Pharm Res; 2008 Jan; 25(1):87-103. PubMed ID: 17985216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier.
    Cevc G; Gebauer D
    Biophys J; 2003 Feb; 84(2 Pt 1):1010-24. PubMed ID: 12547782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting Drugs Across Biological Barriers.
    Yang R; Wei T; Goldberg H; Wang W; Cullion K; Kohane DS
    Adv Mater; 2017 Oct; 29(37):. PubMed ID: 28752600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microphysiological heart-liver body-on-a-chip system with a skin mimic for evaluating topical drug delivery.
    Pires de Mello CP; Carmona-Moran C; McAleer CW; Perez J; Coln EA; Long CJ; Oleaga C; Riu A; Note R; Teissier S; Langer J; Hickman JJ
    Lab Chip; 2020 Feb; 20(4):749-759. PubMed ID: 31970354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laplace Transform Based Modeling of Drug Delivery with Reversible Drug Binding in a Multilayer Tissue.
    Jain A; Pontrelli G; McGinty S
    Pharm Res; 2024 Jun; 41(6):1093-1107. PubMed ID: 38862720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human skin models: From healthy to disease-mimetic systems; characteristics and applications.
    Moniz T; Costa Lima SA; Reis S
    Br J Pharmacol; 2020 Oct; 177(19):4314-4329. PubMed ID: 32608012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular carriers for dermal drug delivery.
    Sinico C; Fadda AM
    Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.